Wednesday, July 18, 2012 8:13:40 AM
Highest close in last 42 months, .18
That is completely untrue. In fact you only need to go back to June 29 of last year to see that statement is false
http://finance.yahoo.com/q/hp?s=ELTP&a=03&b=9&c=2011&d=05&e=30&f=2011&g=d
Date Open High Low Close Volume Adj Close*
Jun 30, 2011 0.19 0.19 0.14 0.17 6,580,900 0.17
Jun 29, 2011 0.19 0.20 0.19 0.19 4,219,300 0.19
Jun 28, 2011 0.19 0.21 0.17 0.18 4,976,600 0.18
Jun 27, 2011 0.18 0.21 0.18 0.19 7,214,300 0.19
Jun 24, 2011 0.16 0.18 0.16 0.18 4,724,700 0.18
Jun 23, 2011 0.16 0.16 0.15 0.16 1,485,400 0.16
Jun 22, 2011 0.13 0.15 0.13 0.15 1,229,700 0.15
Jun 21, 2011 0.13 0.14 0.13 0.14 1,243,100 0.14
Jun 20, 2011 0.15 0.15 0.13 0.14 2,181,100 0.14
Jun 17, 2011 0.16 0.16 0.14 0.14 1,548,600 0.14
Jun 16, 2011 0.15 0.16 0.14 0.14 2,285,900 0.14
Jun 15, 2011 0.16 0.16 0.15 0.15 2,454,900 0.15
Jun 14, 2011 0.16 0.16 0.15 0.16 805,700 0.16
Jun 13, 2011 0.15 0.16 0.15 0.15 1,738,200 0.15
Jun 10, 2011 0.16 0.17 0.15 0.16 2,854,200 0.16
Jun 9, 2011 0.16 0.16 0.15 0.15 1,911,400 0.15
Jun 8, 2011 0.15 0.16 0.15 0.15 2,184,200 0.15
Jun 7, 2011 0.17 0.17 0.15 0.15 2,778,800 0.15
Jun 6, 2011 0.16 0.18 0.15 0.16 5,779,500 0.16
Jun 3, 2011 0.15 0.16 0.15 0.15 2,224,700 0.15
Jun 2, 2011 0.16 0.16 0.15 0.15 2,408,500 0.15
Jun 1, 2011 0.15 0.16 0.15 0.15 5,769,400 0.15
May 31, 2011 0.13 0.15 0.13 0.14 2,555,400 0.14
May 27, 2011 0.14 0.15 0.13 0.14 3,828,600 0.14
May 26, 2011 0.14 0.14 0.13 0.14 4,732,600 0.14
May 25, 2011 0.14 0.14 0.12 0.14 19,954,200 0.14
May 24, 2011 0.16 0.17 0.12 0.15 9,905,000 0.15
May 23, 2011 0.20 0.21 0.16 0.17 12,101,100 0.17
May 20, 2011 0.14 0.21 0.14 0.19 25,691,700 0.19
May 19, 2011 0.12 0.13 0.12 0.13 2,176,600 0.13
May 18, 2011 0.13 0.13 0.12 0.12 2,248,500 0.12
May 17, 2011 0.14 0.14 0.12 0.12 3,708,100 0.12
May 16, 2011 0.14 0.14 0.13 0.13 3,232,600 0.13
May 13, 2011 0.13 0.14 0.12 0.13 3,049,300 0.13
May 12, 2011 0.12 0.14 0.11 0.13 10,500,000 0.13
May 11, 2011 0.13 0.13 0.11 0.12 8,600,000 0.12
May 10, 2011 0.14 0.14 0.13 0.13 5,511,400 0.13
May 9, 2011 0.14 0.14 0.14 0.14 3,236,800 0.14
May 6, 2011 0.15 0.15 0.14 0.14 4,118,600 0.14
May 5, 2011 0.13 0.15 0.13 0.15 5,100,000 0.15
May 4, 2011 0.14 0.16 0.14 0.14 7,599,600 0.14
May 3, 2011 0.18 0.18 0.14 0.14 11,100,000 0.14
May 2, 2011 0.20 0.20 0.16 0.18 5,005,300 0.18
Apr 29, 2011 0.18 0.19 0.17 0.18 7,942,600 0.18
Apr 28, 2011 0.20 0.20 0.17 0.18 6,300,000 0.18
Apr 27, 2011 0.19 0.21 0.18 0.19 8,095,100 0.19
Apr 26, 2011 0.21 0.21 0.18 0.20 11,300,000 0.20
Apr 25, 2011 0.22 0.23 0.20 0.21 5,664,300 0.21
Apr 21, 2011 0.20 0.22 0.20 0.22 7,670,600 0.22
Apr 20, 2011 0.24 0.25 0.19 0.19 14,943,700 0.19
Apr 19, 2011 0.23 0.24 0.20 0.24 14,812,800 0.24
Apr 18, 2011 0.17 0.23 0.17 0.22 15,909,900 0.22
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
